Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial

Chris Smith, Christopher Jarvis, Caroline Free, Chris Smith, Christopher Jarvis, Caroline Free

Abstract

Background: Loss to follow-up (LTFU) in clinical trials is an important source of bias that can affect statistical power and generalisability of findings. The aim of this paper is to assess factors associated with LTFU in the MObile Technology for Improved Family Planning (MOTIF) trial in Cambodia and compare how the result might have varied using different analytical methods.

Methods: Follow-up in the MOTIF trial was 86% at 4 months and 66% at 12 months. For the primary analysis, we undertook a complete case analysis, similar to the approach used in similar trials of interventions delivered by mobile phone to increase contraception use. We conducted an exploratory analysis and found that factors associated with LTFU were young age, lower socio-economic status, not planning to use post-abortion contraception, availability of phone credit and not providing additional contact numbers. We then undertook two analyses to estimate the effect of the intervention on the primary outcome at 4 and 12 months for comparison with the complete case analysis. First, we undertook multiple imputation, and second we conducted an analysis treating all participants' LTFU as non-users of contraception.

Results: Using multiple imputation, we found that the risk ratio was slightly increased at 4 months and slightly decreased at 12 months compared with the complete case analysis. When counting all participants' LTFU as non-users of contraception, we observed that, compared with the complete case analysis, the risk ratio was slightly decreased at 4 months and slightly increased at 12 months. Despite the changes in the risk ratio, use of the different analytical methods did not result in an effect using the complete case analysis becoming statistically significant or vice versa.

Conclusion: Future studies assessing contraception use might anticipate increased attrition amongst younger participants, those of lower socio-economic status or those who do not provide additional contact details. Attrition could be reduced by collecting as many contact details as possible, by providing incentives and possibly by enhanced counselling to groups at higher risk of LTFU on recruitment. Multiple imputation should be considered in addition to complete case analysis if LTFU not missing at random is expected or observed.

Trial registration: ClinicalTrials.gov, NCT01823861 . Registered on 30 March 2013.

Keywords: Attrition; Contraception; Digital health; Family planning; Loss to follow-up; Randomised controlled trial; mHealth.

Conflict of interest statement

Ethics approval and consent to participate

Ethical approval for the MOTIF study was obtained from ethics committees at the London School of Hygiene and Tropical Medicine (reference 6378) and Marie Stopes International (reference 002-13-E) as well as from the Cambodia Human Research Ethics Committee (reference 0036 NECHR). Participants were provided with an information sheet to read, or it was read to them, and provided signed or thumb-printed consent or recorded verbal consent.

Consent for publication

As part of the consent form, participants were asked to agree with the statement, ‘I allow you to write about what I have said during our talk, and I understand that you won’t be using my real name’.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. London: The Cochrane Collaboration. .
    1. Edwards P, Fernandes J, Roberts I, Kuppermann N. Young men were at risk of becoming lost to follow-up in a cohort of head-injured adults. J Clin Epidemiol. 2007;60(4):417–24. doi: 10.1016/j.jclinepi.2006.06.021.
    1. Carpenter J, Bartlett J. Missing data. London: London School of Hygiene & Tropical Medicine; 2016.
    1. Edwards PJ, Roberts I, Clarke MJ, DiGuiseppi C, Wentz R, Kwan I, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev. 2009;3:MR000008.
    1. Smith C, Vannak U, Sokhey L, Ngo TD, Gold J, Khut K, et al. MObile Technology for Improved Family Planning services (MOTIF): study protocol for a randomised controlled trial. Trials. 2013;14:427. doi: 10.1186/1745-6215-14-427.
    1. Hou M, Hurwitz S, Kavanagh E, Fortin J, Goldberg A. Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet Gynecol. 2010;116(3):633–40. doi: 10.1097/AOG.0b013e3181eb6b0f.
    1. Castaño PM, Bynum JY, Andrés R, Lara M, Westhoff C. Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial. Obstet Gynecol. 2012;119(1):14–20. doi: 10.1097/AOG.0b013e31823d4167.
    1. National Institute of Statistics, Directorate General for Health, and ICF International. Cambodia: demographic and health survey 2014. Phnom Penh, Cambodia, and Rockville, MD: Author; 2015. . Accessed 1 July 2017.
    1. Westoff CF. Unmet need for modern contraceptive methods. DHS Analytical Studies 28. Washington, DC: U.S. Agency for International Development; 2012.
    1. Kenward M, Carpenter J. Multiple imputation: current perspectives. Stat Methods Med Res. 2007;16(3):199–218. doi: 10.1177/0962280206075304.
    1. Smith C, Ngo TD, Edwards P, Free C. MObile Technology for Improved Family Planning: update to randomised controlled trial protocol. Trials. 2014;15:440. doi: 10.1186/1745-6215-15-440.

Source: PubMed

3
Tilaa